Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2013-06-12 17:32:34 UTC |
---|
Update Date | 2019-07-23 07:14:33 UTC |
---|
HMDB ID | HMDB0060536 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Norclozapine |
---|
Description | Norclozapine is the major metabolite of Clozapine. Clozapine is an atypical antipsychotic medication used in the treatment of schizophrenia, and is also sometimes used off-label for the treatment of bipolar disorder. Clozapine is extensively metabolized in the liver, via the cytochrome P450 system, to polar metabolites suitable for elimination in the urine and feces. The major metabolite, norclozapine (desmethyl-clozapine), is pharmacologically active. (Wikipedia ) |
---|
Structure | ClC1=CC=C2NC3=CC=CC=C3C(=NC2=C1)N1CCNCC1 InChI=1S/C17H17ClN4/c18-12-5-6-15-16(11-12)21-17(22-9-7-19-8-10-22)13-3-1-2-4-14(13)20-15/h1-6,11,19-20H,7-10H2 |
---|
Synonyms | Value | Source |
---|
8-Chloro-11-(1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine | ChEBI | Demethylclozapine | ChEBI | Desmethylclozapine | ChEBI | N-Desmethyl clozapine | ChEBI | NDMC | ChEBI | 8-Chloro-11-piperazin-1-yl-5H-dibenzo(b,e)(1,4)diazepine | MeSH | Norclozapine | ChEBI |
|
---|
Chemical Formula | C17H17ClN4 |
---|
Average Molecular Weight | 312.797 |
---|
Monoisotopic Molecular Weight | 312.114174271 |
---|
IUPAC Name | 6-chloro-10-(piperazin-1-yl)-2,9-diazatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaene |
---|
Traditional Name | NDMC |
---|
CAS Registry Number | Not Available |
---|
SMILES | ClC1=CC=C2NC3=CC=CC=C3C(=NC2=C1)N1CCNCC1 |
---|
InChI Identifier | InChI=1S/C17H17ClN4/c18-12-5-6-15-16(11-12)21-17(22-9-7-19-8-10-22)13-3-1-2-4-14(13)20-15/h1-6,11,19-20H,7-10H2 |
---|
InChI Key | JNNOSTQEZICQQP-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as dibenzodiazepines. Dibenzodiazepines are compounds containing a dibenzodiazepine moiety, which consists of two benzene connected by diazepine ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzodiazepines |
---|
Sub Class | Dibenzodiazepines |
---|
Direct Parent | Dibenzodiazepines |
---|
Alternative Parents | |
---|
Substituents | - Dibenzodiazepine
- 1,4-benzodiazepine
- Aryl chloride
- Aryl halide
- 1,4-diazinane
- Imidolactam
- Piperazine
- Benzenoid
- Amidine
- Carboxylic acid amidine
- Secondary aliphatic amine
- Azacycle
- Organic 1,3-dipolar compound
- Secondary amine
- Propargyl-type 1,3-dipolar organic compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Organohalogen compound
- Organochloride
- Organonitrogen compound
- Organopnictogen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Norclozapine,1TMS,isomer #1 | C[Si](C)(C)N1C2=CC=C(Cl)C=C2N=C(N2CCNCC2)C2=CC=CC=C21 | 2810.0 | Semi standard non polar | 33892256 | Norclozapine,1TMS,isomer #1 | C[Si](C)(C)N1C2=CC=C(Cl)C=C2N=C(N2CCNCC2)C2=CC=CC=C21 | 2698.0 | Standard non polar | 33892256 | Norclozapine,1TMS,isomer #1 | C[Si](C)(C)N1C2=CC=C(Cl)C=C2N=C(N2CCNCC2)C2=CC=CC=C21 | 4157.1 | Standard polar | 33892256 | Norclozapine,1TMS,isomer #2 | C[Si](C)(C)N1CCN(C2=NC3=CC(Cl)=CC=C3NC3=CC=CC=C23)CC1 | 2999.6 | Semi standard non polar | 33892256 | Norclozapine,1TMS,isomer #2 | C[Si](C)(C)N1CCN(C2=NC3=CC(Cl)=CC=C3NC3=CC=CC=C23)CC1 | 3020.0 | Standard non polar | 33892256 | Norclozapine,1TMS,isomer #2 | C[Si](C)(C)N1CCN(C2=NC3=CC(Cl)=CC=C3NC3=CC=CC=C23)CC1 | 4594.7 | Standard polar | 33892256 | Norclozapine,2TMS,isomer #1 | C[Si](C)(C)N1CCN(C2=NC3=CC(Cl)=CC=C3N([Si](C)(C)C)C3=CC=CC=C23)CC1 | 2943.3 | Semi standard non polar | 33892256 | Norclozapine,2TMS,isomer #1 | C[Si](C)(C)N1CCN(C2=NC3=CC(Cl)=CC=C3N([Si](C)(C)C)C3=CC=CC=C23)CC1 | 2986.8 | Standard non polar | 33892256 | Norclozapine,2TMS,isomer #1 | C[Si](C)(C)N1CCN(C2=NC3=CC(Cl)=CC=C3N([Si](C)(C)C)C3=CC=CC=C23)CC1 | 3965.4 | Standard polar | 33892256 | Norclozapine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C2=CC=C(Cl)C=C2N=C(N2CCNCC2)C2=CC=CC=C21 | 2956.9 | Semi standard non polar | 33892256 | Norclozapine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C2=CC=C(Cl)C=C2N=C(N2CCNCC2)C2=CC=CC=C21 | 2906.9 | Standard non polar | 33892256 | Norclozapine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C2=CC=C(Cl)C=C2N=C(N2CCNCC2)C2=CC=CC=C21 | 4212.6 | Standard polar | 33892256 | Norclozapine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1CCN(C2=NC3=CC(Cl)=CC=C3NC3=CC=CC=C23)CC1 | 3224.2 | Semi standard non polar | 33892256 | Norclozapine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1CCN(C2=NC3=CC(Cl)=CC=C3NC3=CC=CC=C23)CC1 | 3209.3 | Standard non polar | 33892256 | Norclozapine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1CCN(C2=NC3=CC(Cl)=CC=C3NC3=CC=CC=C23)CC1 | 4813.4 | Standard polar | 33892256 | Norclozapine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN(C2=NC3=CC(Cl)=CC=C3N([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)CC1 | 3283.6 | Semi standard non polar | 33892256 | Norclozapine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN(C2=NC3=CC(Cl)=CC=C3N([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)CC1 | 3380.0 | Standard non polar | 33892256 | Norclozapine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN(C2=NC3=CC(Cl)=CC=C3N([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)CC1 | 4086.5 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Norclozapine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0016-9080000000-e5a1e856cf588ec3b2c6 | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Norclozapine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Norclozapine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norclozapine 10V, Positive-QTOF | splash10-03di-0009000000-7cf412ccc6a185a32893 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norclozapine 20V, Positive-QTOF | splash10-03di-0039000000-447fe506f0de08f3a236 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norclozapine 40V, Positive-QTOF | splash10-0006-2290000000-c1c2dd97da1db1b554a6 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norclozapine 10V, Negative-QTOF | splash10-03di-0009000000-c0fb9c4f98b955f22ee4 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norclozapine 20V, Negative-QTOF | splash10-03di-0019000000-2a2da1946b96480241e4 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norclozapine 40V, Negative-QTOF | splash10-0006-9060000000-b9a39c856d2c8566d39b | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norclozapine 10V, Positive-QTOF | splash10-03di-0009000000-19ee5c40a0267a7c3d31 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norclozapine 20V, Positive-QTOF | splash10-03di-0019000000-cb30f19e8d9094be09aa | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norclozapine 40V, Positive-QTOF | splash10-01r6-1091000000-16307b800b31dddedd25 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norclozapine 10V, Negative-QTOF | splash10-03di-0009000000-36527b79e8e0db55602b | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norclozapine 20V, Negative-QTOF | splash10-03di-1009000000-5ddb83e6baa29fcab0a5 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norclozapine 40V, Negative-QTOF | splash10-05ai-4192000000-fda9bbc6faa449b756b5 | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|
General References | - Ekstrom J, Godoy T, Riva A: N-Desmethylclozapine exerts dual and opposite effects on salivary secretion in the rat. Eur J Oral Sci. 2010 Feb;118(1):1-8. doi: 10.1111/j.1600-0722.2009.00696.x. [PubMed:20156258 ]
- Couchman L, Morgan PE, Spencer EP, Flanagan RJ: Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993-2007. Ther Drug Monit. 2010 Aug;32(4):438-47. doi: 10.1097/FTD.0b013e3181dad1fb. [PubMed:20463634 ]
- Ertugrul A, Ozdemir H, Vural A, Dalkara T, Meltzer HY, Saka E: The influence of N-desmethylclozapine and clozapine on recognition memory and BDNF expression in hippocampus. Brain Res Bull. 2011 Feb 1;84(2):144-50. doi: 10.1016/j.brainresbull.2010.11.014. Epub 2010 Dec 4. [PubMed:21134422 ]
- Godoy T, Riva A, Ekstrom J: Clozapine-induced salivation: interaction with N-desmethylclozapine and amisulpride in an experimental rat model. Eur J Oral Sci. 2011 Aug;119(4):275-81. doi: 10.1111/j.1600-0722.2011.00832.x. [PubMed:21726287 ]
- Heusler P, Bruins Slot L, Tourette A, Tardif S, Cussac D: The clozapine metabolite N-desmethylclozapine displays variable activity in diverse functional assays at human dopamine D(2) and serotonin 5-HT(1)A receptors. Eur J Pharmacol. 2011 Nov 1;669(1-3):51-8. doi: 10.1016/j.ejphar.2011.07.031. Epub 2011 Aug 5. [PubMed:21835172 ]
- Humbert-Claude M, Davenas E, Gbahou F, Vincent L, Arrang JM: Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo. Psychopharmacology (Berl). 2012 Mar;220(1):225-41. doi: 10.1007/s00213-011-2471-5. Epub 2011 Sep 13. [PubMed:21912901 ]
|
---|